Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever

Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it ...
Forbes

What Farmer J’s $23 Million Raise And U.S. Expansion Signals For Fast-Casual

Forbes contributors publish independent expert analyses and insights. Lela is a London-based writer and editor who covers food and drink. Farmer J began, as many food businesses do, with a problem its ...
The Nation

Has J Street Gone Along With Genocide?

The “pro-Israel, pro-peace” advocacy group has seen its credibility shredded over its floundering response to the war on Gaza. Jeremy Ben-Ami, president of J Street, speaking at the 2022 J Street ...
Reuters

J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal

J&J's $132 per-share offer implies 39% premium Deal could kick off spree of activity in sector in 2025 CEO says such large deals not common The deal would help accelerate growth in J&J's drugs ...